Status:
COMPLETED
Hepatitis B Virus Reactivation: a Cautionary Event After Liver Transplantation for Patients With Hepatocellular Carcinoma
Lead Sponsor:
Zhejiang University
Conditions:
Liver Transplant; Complications
Eligibility:
All Genders
18-75 years
Brief Summary
Highly active hepatitis B virus (HBV) is known to be associated with poor outcomes in patients with hepatocellular carcinoma (HCC). This study aims to investigate the relationship between HBV status a...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- (1) preoperative diagnosis of HBV-related HCC and (2) pathologically confirmed HCC.
- Exclusion criteria
- (1) non-HBV-related HCC; (2) simultaneous presence of other tumors; (3) re-transplantation; (4) presence of portal vein tumor thrombus; and (5) a survival time of less than 90 days.
Exclusion
Key Trial Info
Start Date :
January 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2023
Estimated Enrollment :
920 Patients enrolled
Trial Details
Trial ID
NCT06114251
Start Date
January 1 2015
End Date
June 1 2023
Last Update
November 2 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.